The Solubility Company Secures Seed Funding
The Solubility Company Secures Seed Funding for US Expansion via Investors Led by Microsize LLC Helsinki, Finland, July 10, 2023 – The Solubility Company Oy proudly announces a strategic investment from a US-based pharma investment group composed of preeminent pharmaceutical CRO/CDMO leaders led by Microsize LLC. The investment accelerates The Solubility Company’s mission to revolutionize […]
Seasons Greetings
Wishing all our clients and friends around the world a peaceful festive season and a happy 2023!
Japanese Patent Granted!
The Japan Patent Office Grants Patent
SPA™ Assists Formulators
Check out our recent White Paper on SPA™! Rationalised formulation development using less than 1 milligram of API!
Sounding too good to be true? Check out our follow-up White Paper on SPA™ solubility data assisted formulation modelling, a collaborative work between The Solubility Company and amofor!
New White Paper – SPA™ Dissolution Rate Assay
Following on from our well received eChalk by our CEO Sami Svanbäck, hosted by the AAPS we are excited to release our new White Paper on SPA™ Dissolution Rate Assays
SPA™ Assisted Modelling
Check out our recent White Paper on SPA™ solubility data assisted modelling, a collaborative work together with another exciting startup amofor!
Chinese Patent Granted
China National Intellectual Property Administration grants Patent!
Updated SPA™ vs ShakeFlask Validation
The extended performance comparison between the SPA™ assay and the industry standard shake-flask assay highlights the benefits of small- scale measurement without sacrificing accuracy.
SPA™ highlighted as an innovative solubility measurement technology addressing the gap at the discovery-development interface.
Researchers at Eli Lilly and Company, AstraZeneca, Novartis, and Pfizer recently highlighted the critical role of solubility measurement in drug discovery and development, addressing the current gap at the discovery-development interface. “Solubility is a key physicochemical property for the success of any drug candidate” but “an artificial boundary can exist at the discovery-development interface”. The […]
Seasons Greetings
All the team at The Solubility Company wishes a Happy Holidays and a prosperous 2022 to all our friends and collaborators around the world! In the past year we have continued to grow with the help of our Clients and Collaborators, whilst redefining solubility analysis with new service offerings and we are looking forward to […]
